GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

VMD · Mar 31, 2025

VIEMED HEALTHCARE, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001729149-25-000096General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

6.63% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

26.19% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

4.83% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

16.87% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

7.63% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

56.28% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

6.50% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

1.35% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

3.91% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History10 statesHistory building
Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20250/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
1.78%
Current
6.63%
Delta
4.85%
Capex Intensity Increased
Previous
16.84%
Current
26.19%
Delta
9.34%
Cash Generation Decreased
Previous
17.43%
Current
4.83%
Delta
-12.60%
Inventory Pressure Increased
Previous
1.93%
Current
7.63%
Delta
5.70%
Margin Decreased
Previous
59.40%
Current
56.28%
Delta
-3.12%
Profitability Decreased
Previous
7.98%
Current
6.50%
Delta
-1.49%
R And D Intensity Decreased
Previous
1.37%
Current
1.35%
Delta
-0.02%
Sbc Intensity Increased
Previous
2.80%
Current
3.91%
Delta
1.11%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · VMD Fundamental State →Has State · VIEMED HEALTHCARE, INC. →Transitioned To · VMD Fundamental State →Transitioned To · VMD BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · VMD CAPEX_INTENSITY_INCREASED →Transitioned To · VMD CASH_GENERATION_DECREASED →Transitioned To · VMD INVENTORY_PRESSURE_INCREASED →Transitioned To · VMD MARGIN_DECREASED →Transitioned To · VMD PROFITABILITY_DECREASED →Transitioned To · VMD R_AND_D_INTENSITY_DECREASED →Transitioned To · VMD SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.